Stage IV Colorectal Cancer Active Not Recruiting Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02873195Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal CancerTreatment
NCT02292758Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryTreatment